SALIX PHARMACEUTICALS LTD Net Income
SALIX PHARMACEUTICALS LTD reported Net Income of -$287.64 million for the 3-month period ending 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Income Statement
us-gaap:NetIncomeLoss · last filed 2015-03-02
- SALIX PHARMACEUTICALS LTD net income (loss) attributable to parent for the quarter ending 2014-12-31 was -$287.64M, a 818.41% decline year-over-year.
- SALIX PHARMACEUTICALS LTD net income (loss) attributable to parent for the quarter ending 2014-09-30 was -$88.59M, a 287.18% decline year-over-year.
- SALIX PHARMACEUTICALS LTD net income (loss) attributable to parent for the quarter ending 2014-06-30 was $418.00K, a 98.01% decline year-over-year.
- SALIX PHARMACEUTICALS LTD net income (loss) attributable to parent for the quarter ending 2014-03-31 was -$34.58M, a 254.08% decline year-over-year.
- SALIX PHARMACEUTICALS LTD net income (loss) attributable to parent for fiscal 2014 was -$414.91M, a 417.18% decline from fiscal 2013.
- SALIX PHARMACEUTICALS LTD net income (loss) attributable to parent for fiscal 2013 was $130.81M, a 103.61% increase from fiscal 2012.
- SALIX PHARMACEUTICALS LTD net income (loss) attributable to parent for fiscal 2012 was $64.25M, a 26.49% decline from fiscal 2011.
- SALIX PHARMACEUTICALS LTD net income (loss) attributable to parent for fiscal 2011 was $87.40M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | -$287.64M 10-K · filed 2015-03-02 | -$380.75M derived: sum of 2 quarters · filed 2015-03-02 | -$380.33M derived: sum of 3 quarters · filed 2015-03-02 | -$414.91M 10-K · filed 2015-03-02 | ||||
| 2014-09-30 | -$88.59M 10-Q · filed 2014-11-07 | -$92.69M derived: sum of 2 quarters · filed 2015-03-02 | -$127.27M 10-Q/A · filed 2015-03-02 | -$129.19M 10-Q · filed 2014-11-07 | -$87.23M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2014-06-30 | $418.00K 10-Q/A · filed 2015-03-02 | $3.28M 10-Q · filed 2014-08-08 | -$34.16M 10-Q/A · filed 2015-03-02 | -$40.59M 10-Q · filed 2014-08-08 | $5.88M derived: sum of 3 quarters · filed 2015-03-02 | $53.21M derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2014-03-31 | -$34.58M 10-Q/A · filed 2015-03-02 | -$43.87M 10-Q · filed 2014-05-09 | $5.46M derived: sum of 2 quarters · filed 2015-03-02 | $52.79M derived: sum of 3 quarters · filed 2015-03-02 | $73.79M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2013-12-31 | $40.04M 10-K · filed 2015-03-02 | $52.26M 10-K · filed 2014-02-28 | $87.37M derived: sum of 2 quarters · filed 2015-03-02 | $108.37M derived: sum of 3 quarters · filed 2015-03-02 | $130.81M 10-K · filed 2015-03-02 | $143.03M 10-K · filed 2014-02-28 | ||
| 2013-09-30 | $47.33M 10-K · filed 2015-03-02 | $68.33M derived: sum of 2 quarters · filed 2015-03-02 | $90.77M 10-Q/A · filed 2015-03-02 | $108.39M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-06-30 | $21.00M 10-K · filed 2015-03-02 | $43.44M 10-Q/A · filed 2015-03-02 | $61.06M derived: sum of 3 quarters · filed 2015-03-02 | $77.60M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2013-03-31 | $22.44M 10-K · filed 2015-03-02 | $40.06M derived: sum of 2 quarters · filed 2015-03-02 | $56.60M derived: sum of 3 quarters · filed 2015-03-02 | $66.55M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-12-31 | $17.62M 10-K · filed 2015-03-02 | $34.16M derived: sum of 2 quarters · filed 2015-03-02 | $44.11M derived: sum of 3 quarters · filed 2015-03-02 | $64.25M 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | $16.54M 10-K · filed 2015-03-02 | $26.49M derived: sum of 2 quarters · filed 2015-03-02 | $46.62M 10-Q · filed 2013-11-08 | $80.22M derived: sum of 4 quarters · filed 2015-03-02 | ||||
| 2012-06-30 | $9.95M 10-K · filed 2015-03-02 | $20.13M 10-Q · filed 2012-08-09 | $30.09M 10-Q · filed 2013-08-09 | $63.68M derived: sum of 3 quarters · filed 2015-03-02 | $97.96M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2012-03-31 | $20.13M 10-K · filed 2015-03-02 | $9.95M 10-Q · filed 2012-05-08 | $53.73M derived: sum of 2 quarters · filed 2015-03-02 | $88.01M derived: sum of 3 quarters · filed 2015-03-02 | $107.25M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2011-12-31 | $33.59M 10-K · filed 2013-03-01 | $67.87M derived: sum of 2 quarters · filed 2013-03-01 | $87.12M derived: sum of 3 quarters · filed 2013-03-01 | $87.40M 10-K · filed 2015-03-02 | ||||
| 2011-09-30 | $34.28M 10-K · filed 2013-03-01 | $53.53M derived: sum of 2 quarters · filed 2013-03-01 | $53.80M 10-Q · filed 2012-11-08 | $78.28M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-06-30 | $19.25M 10-K · filed 2013-03-01 | $19.52M 10-Q · filed 2012-08-09 | $44.00M derived: sum of 3 quarters · filed 2013-03-01 | $41.27M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-03-31 | $278.00K 10-K · filed 2013-03-01 | $24.75M derived: sum of 2 quarters · filed 2013-03-01 | $22.03M derived: sum of 3 quarters · filed 2013-03-01 | -$1.58M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2010-12-31 | $24.47M 10-K · filed 2012-02-28 | $21.75M derived: sum of 2 quarters · filed 2012-02-28 | -$1.86M derived: sum of 3 quarters · filed 2012-02-28 | -$27.06M 10-K · filed 2013-03-01 | ||||
| 2010-09-30 | -$2.72M 10-K · filed 2012-02-28 | -$26.33M derived: sum of 2 quarters · filed 2012-02-28 | -$51.53M 10-Q · filed 2011-11-09 | |||||
| 2010-06-30 | -$23.61M 10-K · filed 2012-02-28 | -$48.81M 10-Q · filed 2011-08-09 | ||||||
| 2010-03-31 | -$25.20M 10-K · filed 2012-02-28 | |||||||
| 2009-12-31 | -$43.62M 10-K · filed 2012-02-28 |